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A cross sectional study of dengue virus infection in 
febrile patients presumptively diagnosed of malaria in 




In Nigeria, where malaria is endemic, greater than 70% of  febrile illnesses are treated presumptively as malaria, often without a 
laboratory evaluation for other possible causes of  fever. This cross-sectional study evaluated the presence of  dengue virus infection in 
febrile patients, presumptively diagnosed of  malaria infections in the clinic.
Methodology
Blood samples were collected from 529 febrile patients (246 in Jos and 283 in Maiduguri) attending the general outpatient clinics of  
the Jos University Teaching Hospital (JUTH) and the University of  Maiduguri Teaching Hospital (UMTH) and tested for anti-dengue 
immunoglobulin M (IgM) and immunoglobulin G (IgG), as well as anti-non-structural protein (NS1) by ELISA. The samples were also 
evaluated for presence of  P. falciparum malaria parasites by microscopic examination of  Giemsa-stained blood smears. 
Results
The prevalence of  confirmed, highly suggestive and probable dengue virus infections categorized in relation to duration of  illness since 
onset of  fever were 2.3%, 5.5% and 1.5% respectively, while the prevalence of  anti-flavivirus IgG and IgM seropositivity was 11.7%. In 
a total of  117 (22.1%) patients (32 in Jos, 85 in Maiduguri), malaria parasites were detected by blood smear microscopy, out of  which 
7 (6%) also had a positively confirmed, highly suggestive or probable dengue test result.
Conclusion
Although the high cross-reactivity of  anti-flavivirus antibodies should be taken into account in the interpretation of  the seroprevalence 
data, our findings suggest a significant presence of  dengue virus in this environment, some of  which may otherwise be misdiagnosed 
as malaria. These findings are strong enough to recommend serological screening for anti-dengue virus titer and NS1 antigen for all 
febrile patients, as part of  fever diagnostic protocols in tropical regions. Given the prevalence of  dengue virus infections, there is also 
a need for a dengue control program and public education to prevent outbreaks and occurrence of  severe dengue complications. 
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Introduction
Dengue virus is a ribonucleic acid (RNA) virus belonging to 
the genus Flavivirus in the family of  Flaviviridae. The virus, 
which has four serotypes designated Den-1, Den-2, Den-3 and 
Den-4, is transmitted by the mosquito Aedesaegypti and causes 
a disease which manifests as dengue, with or without warning 
signs (classical dengue fever) or severe dengue.1  Classical 
dengue fever, the most common type of  dengue illness, is 
characterized by sudden onset of  fever, headache, anorexia, 
malaise, muscle and joint pains, rash and lymphadenopathy.1,2 
Severe dengue is associated with dengue shock, evidenced by 
plasma leakage, haemorrhage and features of  severe organ 
dysfunction, such as markedly elevated liver enzymes and 
impaired consciousness1,2. Case fatality rate of  severe dengue 
may be in excess of  5% and figures as high as 44% have 
been documented1-3. The worldwide incidence of  dengue 
has risen 30-fold in the last 50 years4. More countries are 
reporting their first outbreaks and these outbreaks severely 
disrupt communities and drain economies4,5. Today, dengue 
ranks as one of  the most important mosquito-borne viral 
diseases in the world, making the human and economic costs 
substantial4,6. Fifty million dengue infections are estimated 
to occur annually and approximately 2.5 billion people 
live in dengue endemic countries4. The first documented 
case of  dengue in man was in Nigeria in the 1960s7. From 
August, 1964, to December, 1968, 32 strains of  dengue virus 
were recovered from febrile patients seen at the University 
College Hospital, Ibadan, Nigeria7. Since then, several other 
studies have identified dengue virus infections in different 
geographical regions in the country8-13. A 1977 serosurvey in 
the general population reported a 30% prevalence of  dengue 
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neutralizing antibody on the Jos Plateau and 33% in the Sudan 
savanna zone in northern Nigeria8. In the rainforest zone, 
prevalence of  dengue neutralizing antibodies was reported 
to be 45%8. There have been recent reports of  dengue and its 
co-infection with malaria in patients in northern Nigeria14-17. 
The emergence of  severe dengue in Nassarawa state of  north 
central Nigeria and Kaduna state of  North West, Nigeria, in 
2014 (Directorate of  Public Health, Kaduna and Nassarawa 
State Ministries of  Health, 2014, personal communication), 
brings new focus to the problem posed by dengue in our 
environment. Despite these reports of  dengue infections and 
severe dengue, it is still not a reportable disease in Nigeria and 
in most African countries with most cases left undiagnosed 
or misdiagnosed as malaria18,19. In many healthcare facilities 
in Africa, malaria is recognized as the main cause of  acute 
febrile illness, with enteric fever coming a distant second14-17. 
Most fever screening protocols in these institutions test for 
only malaria and sometimes enteric fever, while overlooking 
other causes of  acute febrile illnesses, such as dengue fever 
virus and many other bacterial and viral causes of  fever14-17.
Therefore, the objective of  this study was to determine the 
proportion of  febrile patients with dengue fever infection 
and the proportion of  dengue and malaria co-infection in 
patients clinically suspected to be infected with Plasmodium in 
two northern Nigerian teaching hospitals.
Methods
Study design and recruitment of participants
This was a prospective cross-sectional study conducted at 
the Jos University Teaching Hospital (JUTH) in North 
CentralNigeria and the University of  Maiduguri Teaching 
Hospital (UMTH) in North East Nigeria between March 
and August, 2014, during the rainy season. Informed consent 
was sought from patients who met the inclusion criteria of  
fever (axillary temperature >37.8°C) and were clinically 
diagnosed or suspected to have malaria infection at the 
general outpatient clinics of  the two hospitals. Patients who 
met the inclusion criteria and gave consent to participate 
were recruited into the study. Ethical clearance was obtained 
from the ethics review boards of  both institutions. Relevant 
clinical and demographic data were collected from patients 
by means of  a questionnaire. 
Laboratory procedures for malaria diagnosis
Blood samples were collected from all consenting participants 
by venipuncture. Malaria parasitemia was determined by 
Giemsa stained thick and thin film microscopy20. Thick 
and thin blood films were prepared using clean grease-free 
non-silicate glass slides. The films were air dried without 
convection, and stained with 10% freshly prepared Giemsa 
stain maintained at a PH of  7.2. Thin blood films were 
fixed with 100% methanol prior to staining. The stained 
blood films were viewed under a light microscope at x1000 
magnification (X100 oil immersion lens). The diagnosis of  
malaria was based on the identification of  asexual stages 
of  Plasmodium on the thick blood smears, while thin blood 
smears were used to identify species of  Plasmodium. If  no 
parasite was seen, blood films were declared negative. Each 
slide was read independently by two trained microscopists. 
In the event of  discordant results, the slide was examined by 
a third microscopist.
Laboratory procedure for dengue virus diagnoses
Serum was separated from the blood samples by 
centrifugation at 1500g for 4 minutes and tested for NS1 
antigens and presence of  antibodies to dengue virus in 
the laboratory by standard ELISA techniques1,21,22. Dengue 
NS1 antigen, IgM and IgG assays were performed using 
a sandwich format microplate enzyme immunoassay for 
the detection of  dengue virus NS1 antigen, IgM and IgG 
antibodies in human serum or plasma. Panbio dengue 
virus NS1, IgM and IgG ELISA kits were used and tests 
performed as described by the manufacturers23,24. In this 
semi-quantitative microassay, a positive ELISA result was 
defined as having an index value >1.123,24. All samples were 
processed in the medical microbiology laboratories of  both 
hospitals. Aseptic techniques, universal precautions and 
quality control measures were strictly observed from sample 
collection to processing in the laboratory. 
Diagnostic criteria for categorization of patients
Patients were categorized into the following classes taking 
into account the serology result and the duration of  illness 
since onset of  fever: (i) Confirmed dengue (positive anti-
dengue IgM + positive for NS1 antigen within 7 days of  
fever onset, (ii) highly suggestive of  dengue (positive anti-
dengue IgM or positive for NS1 antigen after 7 days of  
fever onset or as described in table 2, (iii) probable dengue 
(either positive anti-dengue IgM or positive for NS1 and as 
described in table 2), and (iv) positive anti-flavivirus IgG. A 
detailed description of  this categorization is shown in table 
2.
Data analyses
All data generated were collated, processed and analyzed 
with EPI info version 3.5.2 statistical software (CDC, 
Atlanta, GA, USA). Continuous variables were expressed as 
means ± standard deviation (SD), while categorical variables 
were expressed as proportions. Chi-square test was used 
to compare categorical variables while mean values of  two 
groups were compared using Student “t” test. P-value of  
<0.05 was considered significant.
Results
The demographic characteristics of  all participants in both 
study sites are presented in table 1. A total of  529 febrile 
patients were recruited for the study; 246 were from Jos and 
283 were from Maiduguri; 179 (33.8%) were men and 350 
(66.2%) were women, with a male: female ratio of  1:2.  The 
participants in Jos were younger than those in Maiduguri 
(21.4 ± 18.0 years vs. 33.4 ± 13.8 years, p<0.001). The IgM 
antibody and NS1 antigen results of  individual patients were 
interpreted in correlation to the duration of  febrile illness 
at the time of  sample collection. This interpretation was to 
account for the expected immunological response to dengue 
virus infection from the time of  onset of  illness (positive 
NS1 antigen within the first 2 to 7 days of  onset of  illness, 
positive IgM within 3 to 10 days from onset of  illness and 
positive IgG after 10 days of  onset or during a secondary 
infection). The proportions of  confirmed dengue, highly 
suggestive of  dengue, probable dengue and anti-flavivirus 
IgG seropositivity in the entire population were 2.3%, 5.5%, 
1.5% and 11.7%, respectively (figure 1a).
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Table 1: Demographic characteristics of all the patients studied for dengue virus and malaria infection in Jos and Maiduguri, 
Nigeria
As shown in table 2, we categorized study participants into the following classes taking into account the serologic finding 
and the duration of  illness since onset of  fever: (i) confirmed dengue, (ii) highly suggestive of  dengue, (iii) probable dengue 
(iv) anti-flavivirus IgG and IgM positive, and (v) negative serology (See table 2 for details). 











Confirmed Dengue Positive IgM  +  PositiveNS1 Ag 
within 7 days of fever onset
12 (2.3) 7 (2.9) 5 (1.8)
Highly Suggestive of Dengue Negative IgM + Positive NS1 Ag 
within 7 days of fever onset
6 (1.1) 4 (1.6) 2 (0.7)
Positive IgM + Positive NS1 Ag 
after 7 days of fever onset
1 (0.002) 1 (0.004) 0 (0.0)
Positive IgM + Negative NS1 Ag 
after 7 days of fever onset
22 (4.2) 16 (6.5) 6 (2.1)
Probable Dengue Positive IgM  +  Negative NS1 Ag 
within 7 days of fever onset
7 (0.01) 5 (0.02) 2 (0.007)
Negative IgM + Positive NS1 Ag 
after 7 days of fever onset
1 (0.002) 1 (0.004) 0 (0.0)
Anti-flavirus IgG Positive Positive IgG only 23 (4.4) 10 (4.1) 13 (4.6)
Anti-flavivirus IgM
And IgG Positive
Positive IgM and IgG 39 (7.4) 22 (8.9) 17 (6.0)
No Dengue Infection Negative for all dengue serologic 
markers including IgM, IgG and 
NS1
418 (79.0) 180 (73.2) 238 (84.1)
                                                      Study Location
Demographic                 Jos (n = 246)         Maiduguri (n = 283)          df                  χ2              p-value
Sex
Male                                   81 (32.9)                 98 (34.6)                    0.17                 1               0.680
Female                             165 (67.1)                185 (65.4)         
Location
Rural                               174 (70.7)                  78 (27.6)                   98.32                1             <0.001
Urban                                72 (29.3)                205 (72.4) 
Age (mean ± SD)            21.4 ± 18.0              33.4 ± 13.8                                                          <0.001
Age categorization 
Children (< 18yrs)         130 (52.9)                   42  (14.8)                  86.63                1             < 0.001
Adult (≥18yrs)               116 (47.1)                 241  (85.2)
Age group (yrs)
< 18                                130  (58.9)                  42 (14.8)
18 – 27                             38  (15.4)                  65 (23.0)                    95.74                5           < 0.001
28 – 37                             32  (13.0)                  86  (30.4)
38 – 47                             25  (10.2)                  62  (21.9)
48 – 57                             16  (6.5)                    13  (4.6)
58 and above                     5   (2.0)                    15 (5.3)
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Compared to patients in Maiduguri, the patients in Jos 
had higher seroprevalence for confirmed (2.9% vs. 1.8%, 
p=0.41), highly suggestive (8.5% vs. 2.8%, p=0.004) and 
probable dengue (2.4% vs. 0.7%, p=0.10), while patients in 
Maiduguri had higher seroprevalence of  anti-flavivirus IgG 
seropositivity (4.6% vs. 4.1%, p=0.77), although this finding 
was only statistically significant for highly suggestive dengue 
serology. 
Out of  the 529 blood samples, 117 (22.1%) were positive 
for malaria parasites(13% (32/246) in Jos and 30% (85/283) 
in Maiduguri). All cases of  malaria parasitemia were caused 
by Plasmodium falciparum. However, 5.3% of  patients were 
positive for both malaria parasite and anti-flavivirus/anti-
dengue serology (28 out of  529 samples; 13 in Jos, 15 in 
Maiduguri). Only 6% (7/117) of  patients who had a malaria 
infection also had confirmed, highly suggestive or probable 
dengue virus infection. The distribution of  dengue virus 
serology among the 412 (77.9 %) malaria negative febrile 
patients and the distribution of  malaria positive and negative 
parasitemia across various dengue virus/antiflavivirus 
categories are shown in figures 1b and 1c respectively. The 
proportions of  confirmed, highly suggestive or probable 
dengue were much higher in patients with negative malaria 
blood smear negative compared to patients with a positive 
malaria blood smear.
 
             
Figure 1 (a): Distribution of dengue serology among febrile patients 
(entire study population, N=529)
Figure 1b: Distribution of  dengue serology among malaria 
smear negative febrile patients, N=412
Figure 1b shows that from the 77.9% (412/529) clinically 
misdiagnosed for malaria, 10.2%(42/412) either had a confirmed, 
highly suggestive or probable dengue serology and a total 
antiflavivirus + dengue serology of  20.1% (83/412) amongst the 
malaria smear negative patients
Discussion
Reported cases of  dengue have increased in a number of  
regions in recent decades, but the epidemiology of  dengue 
in Africa is not clear19. Findings in the current study, using 
dengue serological tests (IgM and IgG antibodies and NS1 
antigen), suggest that transmission of  flaviviruses, such as 
dengue, is still occurring at a considerable proportion in 
Africa. Considering that antibody cross-reactivity between 
dengue and other flaviviruses often occurs4, we classified our 
patients using the combined IgM antibody and NS1 antigen 
results, while factoring in the duration of  illness since the 
onset of  fever. 
Variable seroprevalence rates of  dengue virus infection have 
been reported in different studies in Nigeria7-17,25. Incidentally, 
most of  these studies were either based on anti-dengue 
IgM seropositivity or positive NS1 antigenaemia in febrile 
patients, without necessarily interpreting the two serological 
markers together or relating the serologic findings to the 
onset of  febrile illness. This makes comparison in dengue 
seroprevalence somewhat difficult. Based on anti-dengue 
IgM seropositivity, Idokoet al15 documented seroprevalence 
of  dengue infection of  1.8% among febrile patients in 
Kaduna, North West Nigeria while Oladipoet al25 found that 
17.2% of  apparently healthy individuals in Ogbomosho, 
South West Nigeria, had anti-dengue IgM seropositivity, 
and Adesinaet al13 reported a much higher anti-dengue IgM 
seroprevalence of  25.7% among febrile patients in Ile-Ife, 
South West Nigeria. Using positive NS1 antigenaemia, 2.2% 
of  febrile patients were found to have evidence of  dengue 
virus infection in Jos, North Central Nigeria14, compared to a 
much higher dengue NS1 antigenaemia of  35%, reported in 
febrile patients in Ibadan, South West Nigeria.12 Our finding 
was similar to reports from other parts of  sub-Saharan Africa 
which found a combined anti-flavi virus seroprevalence 
of  21-26.3%26,27. However, Kuniholmet al28, using plaque-
reduction neutralization tests, found 12.5% anti-dengue 
seropositivity in Cameroonian adults undergoing infectious 
diseases surveys.
Furthermore, climatic conditions in the rain forest region 
Figure 1 (c): Distribution of dengue fever/antiflavivirus 
categories in relation to malaria parasitemia
Fig 1c shows that the percentages of confirmed, highly suggestive 
or probabledengue were much higher in patients that were 
malaria blood smear negative (red) compared to patients with a 
positive malaria blood smear (blue). 
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of  Southern Nigeria which supports increased mosquito 
breeding could possibly influence the transmission of  
dengue fever virus more than in the dry Sahel region of  
Northern Nigeria accounting for the variable seroprevalence 
of  dengue virus infection reported in Nigeria and other 
parts of  Africa10-15,25,29. Other factors such as presence of  the 
virus in the environment, sufficient numbers of  susceptible 
population and mosquito vectors are indeed critical to dengue 
transmission29. With demographic changes and observed 
increase in Aedes spp. populations in our environment30, 
increased dengue transmission is likely to occur in many 
parts of  Africa. 
The diagnostic method used is an important factor that could 
have influenced the reported seroprevalence of  dengue virus 
infection in available studies. Compared to the study of  
antibody titers, dengue virus isolation or PCR tests are much 
more specific and reliable31. Molecular detection by PCR was 
not carried out in this study due to cost limitations. However, 
dengue NS1 antigenaemia has proven to be a useful test for 
early diagnosis of  dengue virus infection and in combination 
with anti-dengue IgM antibody tests, it can increase the 
diagnostic efficiency for dengue infection especially in the 
first few days of  illness31. On the other hand, the anti-dengue 
IgG antibody test is not specific for dengue virus infection 
due to frequent cross reactions with other flaviviruses31.
Although anti-dengue IgM is more specific for dengue 
compared to IgG, there is also residual cross-reactivity.31In 
many communities in Nigeria, several flaviviruses co-circulate 
with dengue viruses including yellow fever, West Nile, Usutu, 
Wesselsbron, Uganda S, Zika, Dakar Bat, Potiskum and Banzi 
and cannot be quite reliably differentiated from dengue using 
only antibody assays32-36. In addition, our study showed that 
the percentages of  confirmed or highly suggestive dengue 
serology were much higher in patients with a malaria negative 
blood smear compared to those with a positive blood smear. 
This implies that febrile patients who were categorized as 
either confirmed or highly suggestive of  dengue were also 
more likely to be malaria negative and suggests that dengue 
fever virus was the actual cause of  their febrile illness.
In both study sites, we found twice the number of  female 
versus male patients. This was a random occurrence as our 
sampling method was of  consecutive patients who presented 
at the outpatient department of  both hospitals with a febrile 
illness. Such a demographic occurrence might have been 
due to the higher tendency of  females seeking medical 
care compared to their male counterparts. Additionally, the 
terrorist insurgency in Maiduguri at the time of  this study 
could also explain why there were more women recruited, as 
men were either fighting in the insurgency or already victims 
of  the insurgency. The observed disparity in age distribution 
between the two study sites and the rural–urban disparity 
between patients recruited in Jos and those from Maiduguri 
seem to have stemmed from the terrorist insurgency as 
well. The insurgency may have prevented patients, including 
children, from rural suburbs of  Maiduguri and other parts 
of  the state from coming to the teaching hospital to access 
care. 
Historical data shows that epidemics of  yellow fever 
had occurred in 1952, 1953 and 1969 in Okwoga district, 
Benue-Plateau State8,32, which is close to Jos. Yellow fever 
and dengue fever are transmitted by the same mosquito 
vector of  the Aedes species, which has been found in 
large numbers by some researchers in Jos and other parts 
of  Northern Nigeria, and constituted the most prevalent 
population (72.6%) among the total mosquito population in 
a zoological survey in 200830. Unplanned urbanization is a 
major factor in facilitating the increase of  these mosquito 
populations.33 Accumulation of  non-biodegradable, human-
made containers in and around living areas has provided 
the aquatic environment required by these mosquitoes34,35, 
which is commonly seen in and around Jos and Maiduguri, 
where most of  the patients in this study came from, and an 
obvious potential cause for dengue fever outbreaks. Public 
enlightenment and environmental sanitation will be very 
important to limit the number of  aquatic environments that 
can harbor mosquitoes. Generally, severe dengue is reported 
to be infrequent in sub-Saharan Africa37,38. Although there are 
hypotheses regarding possible immunoprotective capacity of  
the cross-reactivity among flaviviruses33,36, the role of  such a 
phenomenon in the observed low rates of  severe forms of  
dengue in sub-Saharan Africa is unknown19. Further studies 
may be required to probe this possibility.
One may wonder why dengue fever infection is perceived 
to be uncommon in this environment despite serological 
and ecological evidence suggesting otherwise. This  might 
be because febrile illnesses such as malaria, tuberculosis, and 
HIV are endemic in many parts of  sub-Saharan Africa and 
are more easily recognized and diagnosed. Most clinicians 
diagnose and treat for malaria once a patient presents with a 
febrile illness in our setting18. Dengue virus infection is hardly 
considered in the differential diagnosis of  febrile patients in 
most parts of  Africa. This study showed that only one fifth 
of  febrile patients in the entire study population had evidence 
of  malaria infection while others had dengue or remained 
undiagnosed of  the cause of  their febrile illness. It is also 
noteworthy that only about 5% of  all febrile patients had 
evidence of  both malaria parasitaemia and anti-flavi virus 
seropositivity. Other causes of  febrile illnesses such as enteric 
fever, septicaemia, urinary tract infections, Lassa fever and 
other viral fevers, which were not the focus of  the present 
study, are frequently missed in the evaluation of  febrile patients 
in the African setting11,16-18. The implication of  continued 
misdiagnoses and lack of  any sense of  clinical suspicion for 
other causes of  febrile illnesses is imminent outbreaks of  
dengue and other febrile illnesses without warning or public 
health preparedness. Such an occurrence would impose a 
very heavy burden on the already overstretched health care 
systems in many African countries. Suffice to say that malaria 
misdiagnosis or over-diagnosis in the tropics would continue 
to have serious public health and economic consequences 
if  unchecked18. The consequences of  overtreatment and 
unnecessary prescription of  antimalarial therapy to a large 
proportion of  the population (77.9 % in this study) who 
are mostly poor and vulnerable and who in most cases do 
not have any health insurance, include: spending finances on 
unnecessary antimalarial medications, unwarranted adverse 
drug reactions and toxicities and increased risk for selection 
of  antimalarial-resistant parasites, which have the potential 
to cross borders to other countries. 
While our findings elucidate the possible role of  dengue as an 
important cause of  fever in our environment, the limitations 
of  our study deserve to be mentioned. Molecular detection 
of  viral proteins of  Den 1 – 4 in the blood of  participant, 
which would have differentiated secondary from past dengue 
infections and confirmed primary infections, was not carried 
out due to cost limitations. Some of  the IgG, IgM or antigen 
results may not have been true positives due to rheumatoid 
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factor or cross-reactivity in the assay procedure. In particular, 
cross-reactivity of  dengue with other flaviviruses was a major 
limitation for the assays. The absence of  malaria parasite 
density is also acknowledged as a study limitation.
Conclusions
Our study findings suggest that dengue transmission is 
ongoing in northern Nigeria and are strong enough to 
recommend serological screening for dengue virus using 
NS1 antigen and anti-dengue IgM for all febrile patients, 
as part of  fever diagnostic protocols in Africa. In addition, 
adequate training of  clinicians and laboratory workers 
on laboratory diagnosis and case management of  dengue 
should be ensured. Community-based public enlightenment 
programs for preventive measures will also help in reducing 
the transmission of  dengue and other mosquito-borne 
diseases in our environment.
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